Novel IL10 gene family associations with systemic juvenile idiopathic arthritis

被引:0
|
作者
Mark S Fife
Ana Gutierrez
Emma M Ogilvie
Carmel JW Stock
Jane M Samuel
Wendy Thomson
Lisa F Mack
Cathryn M Lewis
Patricia Woo
机构
[1] University College London,Centre of Pediatric and Adolescent Rheumatology, Windeyer Institute for Medical Sciences
[2] University of Manchester,ARC Epidemiology Unit
[3] Guy's,undefined
[4] Kings and St Thomas' School of Medicine,undefined
来源
Arthritis Research & Therapy | / 8卷
关键词
Juvenile Idiopathic Arthritis; Systemic Juvenile Idiopathic Arthritis; Juvenile Idiopathic Arthritis Subtype; sJIA Patient; Juvenile Idiopathic Arthritis Case;
D O I
暂无
中图分类号
学科分类号
摘要
Juvenile idiopathic arthritis (JIA) is the most common cause of chronic childhood disability and encompasses a number of disease subgroups. In this study we have focused on systemic JIA (sJIA), which accounts for approximately 11% of UK JIA cases. This study reports the investigation of three members of the IL10 gene family as candidate susceptibility loci in children with sJIA. DNA from 473 unaffected controls and 172 patients with sJIA was genotyped for a single nucleotide polymorphism (SNP) in IL19 and IL20 and two SNPs in IL10. We examined evidence for association of the four SNPs by single marker and haplotype analysis. Significant differences in allele frequency were observed between cases and controls, for both IL10-1082 (p = 0.031) and IL20-468 (p = 0.028). Furthermore, examination of the haplotypes of IL10-1082 and IL20-468 revealed greater evidence for association (global p = 0.0006). This study demonstrates a significant increased prevalence of the low expressing IL10-1082 genotype in patients with sJIA. In addition, we show a separate association with an IL20 polymorphism, and the IL10-1082A/IL20-468T haplotype. The two marker 'A-T' haplotype confers an odds ratio of 2.24 for sJIA. This positive association suggests an important role for these cytokines in sJIA pathogenesis.
引用
收藏
相关论文
共 50 条
  • [1] Systemic Juvenile Idiopathic Arthritis
    Lee, Jennifer J. Y.
    Schneider, Rayfel
    PEDIATRIC CLINICS OF NORTH AMERICA, 2018, 65 (04) : 691 - +
  • [2] IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
    Giancane, Gabriella
    Minoia, Francesca
    Davi, Sergio
    Bracciolini, Giulia
    Consolaro, Alessandro
    Ravelli, Angelo
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [3] CYTOKINE PROFILE (TNFA, IL1B, IL6, IL10) AND ITS ASSOCIATION WITH CLINICAL FEATURES IN JUVENILE IDIOPATHIC ARTHRITIS
    Nazarova, L. Sh
    Danilko, K., V
    Malievsky, V. A.
    Viktorova, T. V.
    Rakhmatullina, I. R.
    PERIODICO TCHE QUIMICA, 2019, 16 (32): : 583 - 597
  • [4] Systemic juvenile idiopathic arthritis
    Martini, Alberto
    AUTOIMMUNITY REVIEWS, 2012, 12 (01) : 56 - 59
  • [5] Resilience and its associations in children with Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis
    Trachtman, Rebecca
    Samuels, Julie
    Wojtal, Emma
    Feldman, Brian M.
    PEDIATRIC RHEUMATOLOGY, 2023, 21 (01)
  • [6] Resilience and its associations in children with Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis
    Rebecca Trachtman
    Julie Samuels
    Emma Wojtal
    Brian M Feldman
    Pediatric Rheumatology, 21
  • [7] Systemic onset juvenile idiopathic arthritis
    Frosch, M.
    Holzinger, D.
    Roth, J.
    MONATSSCHRIFT KINDERHEILKUNDE, 2012, 160 (03) : 217 - +
  • [8] Etanercept in systemic juvenile idiopathic arthritis
    Russo, RAG
    Katsicas, MM
    Zelazko, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (05) : 723 - 726
  • [9] Systemic onset juvenile idiopathic arthritis
    Frosch, M.
    Holzinger, D.
    Roth, J.
    MONATSSCHRIFT KINDERHEILKUNDE, 2012, 160 (03) : 217 - +
  • [10] Canakinumab for the treatment of systemic juvenile idiopathic arthritis
    Grom, Alexei A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (11) : 1427 - 1435